257 related articles for article (PubMed ID: 29361370)
1. Correlating liver stiffness with disease severity scoring system (DS3) values in Gaucher disease type 1 (GD1) patients.
Serai SD; Naidu AP; Andrew Burrow T; Prada CE; Xanthakos S; Towbin AJ
Mol Genet Metab; 2018 Mar; 123(3):357-363. PubMed ID: 29361370
[TBL] [Abstract][Full Text] [Related]
2. Acoustic radiation force impulse point shear wave elastography of the liver and spleen in patients with Gaucher disease type 1: Correlations with clinical data and markers of disease severity.
Lollert A; Hoffmann C; Lache M; König J; Brixius-Huth M; Hennermann JB; Düber C; Staatz G
Mol Genet Metab; 2020 Jun; 130(2):140-148. PubMed ID: 32245682
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of disease burden and response to treatment in adults with type 1 Gaucher disease using a validated disease severity scoring system (DS3).
Weinreb NJ; Finegold DN; Feingold E; Zeng Z; Rosenbloom BE; Shankar SP; Amato D
Orphanet J Rare Dis; 2015 May; 10():64. PubMed ID: 25994334
[TBL] [Abstract][Full Text] [Related]
4. Multiparametric magnetic resonance imaging of the liver and spleen in Gaucher disease.
Parente DB; de Melo Malta FCM; de Souza Cravo R; Luiz RR; Rotman V; Perez RM; Rodrigues RS
Abdom Radiol (NY); 2024 Apr; ():. PubMed ID: 38642092
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Bone Marrow Infiltration in Non-Neuropathic Gaucher Disease Patients with Use of Whole-Body MRI--A Retrospective Data Analysis.
Laudemann K; Moos L; Mengel KE; Lollert A; Reinke J; Brixius-Huth M; Wagner D; Düber C; Staatz G
Rofo; 2015 Dec; 187(12):1093-8. PubMed ID: 26200566
[TBL] [Abstract][Full Text] [Related]
6. Serum progranulin levels in paediatric patients with Gaucher disease; relation to disease severity and liver stiffness by transient elastography.
Tantawy AA; Adly AA; Ismail EA; Salah NY; Abdel Alem S; Elsantiel HI
Liver Int; 2020 Dec; 40(12):3051-3060. PubMed ID: 32652633
[TBL] [Abstract][Full Text] [Related]
7. A validated disease severity scoring system for adults with type 1 Gaucher disease.
Weinreb NJ; Cappellini MD; Cox TM; Giannini EH; Grabowski GA; Hwu WL; Mankin H; Martins AM; Sawyer C; vom Dahl S; Yeh MS; Zimran A
Genet Med; 2010 Jan; 12(1):44-51. PubMed ID: 20027115
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and predictors of liver fibrosis evaluated by vibration controlled transient elastography in type 1 Gaucher disease.
Nascimbeni F; Cassinerio E; Dalla Salda A; Motta I; Bursi S; Donatiello S; Spina V; Cappellini MD; Carubbi F
Mol Genet Metab; 2018 Sep; 125(1-2):64-72. PubMed ID: 30115580
[TBL] [Abstract][Full Text] [Related]
9. Quantification of Bone Marrow Involvement in Treated Gaucher Disease With Proton MR Spectroscopy: Correlation With Bone Marrow MRI Scores and Clinical Status.
Jaramillo D; Bedoya MA; Wang DJ; Pena AH; Delgado J; Jaimes C; Ho-Fung V; Kaplan P
AJR Am J Roentgenol; 2015 Jun; 204(6):1296-302. PubMed ID: 26001241
[TBL] [Abstract][Full Text] [Related]
10. Are transient and shear wave elastography useful tools in Gaucher disease?
Webb M; Zimran A; Dinur T; Shibolet O; Levit S; Steinberg DM; Salomon O
Blood Cells Mol Dis; 2018 Feb; 68():143-147. PubMed ID: 28063644
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of treatment response to enzyme replacement therapy with Velaglucerase alfa in patients with Gaucher disease using whole-body magnetic resonance imaging.
Laudemann K; Moos L; Mengel E; Lollert A; Hoffmann C; Brixius-Huth M; Wagner D; Düber C; Staatz G
Blood Cells Mol Dis; 2016 Mar; 57():35-41. PubMed ID: 26852653
[TBL] [Abstract][Full Text] [Related]
12. A new framework for evaluating the health impacts of treatment for Gaucher disease type 1.
Ganz ML; Stern S; Ward A; Nalysnyk L; Selzer M; Hamed A; Weinreb N
Orphanet J Rare Dis; 2017 Feb; 12(1):38. PubMed ID: 28219443
[TBL] [Abstract][Full Text] [Related]
13. Controlled attenuation parameter and liver stiffness measurements using transient elastography by FibroScan in Gaucher disease.
Lipiński P; Szymańska-Rożek P; Socha P; Tylki-Szymańska A
Mol Genet Metab; 2020 Feb; 129(2):125-131. PubMed ID: 31704237
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance elastography of liver: influence of intravenous gadolinium administration on measured liver stiffness.
Hallinan JT; Alsaif HS; Wee A; Venkatesh SK
Abdom Imaging; 2015 Apr; 40(4):783-8. PubMed ID: 25331568
[TBL] [Abstract][Full Text] [Related]
15. Retrospective Analysis of Whole-Body Magnetic Resonance Imaging of Bone Manifestations in Long-Term Treated Patients with Gaucher Disease Type 1.
Lollert A; Laudemann K; Mengel E; Hoffmann C; Moos L; Reinke J; Brixius-Huth M; Hennermann JB; Düber C; Staatz G
Klin Padiatr; 2019 Mar; 231(2):52-59. PubMed ID: 30481833
[TBL] [Abstract][Full Text] [Related]
16. Iron storage in liver, bone marrow and splenic Gaucheroma reflects residual disease in type 1 Gaucher disease patients on treatment.
Regenboog M; Bohte AE; Akkerman EM; Stoker J; Hollak CEM
Br J Haematol; 2017 Nov; 179(4):635-647. PubMed ID: 28905365
[TBL] [Abstract][Full Text] [Related]
17. Interplatform reproducibility of liver and spleen stiffness measured with MR elastography.
Yasar TK; Wagner M; Bane O; Besa C; Babb JS; Kannengiesser S; Fung M; Ehman RL; Taouli B
J Magn Reson Imaging; 2016 May; 43(5):1064-72. PubMed ID: 26469708
[TBL] [Abstract][Full Text] [Related]
18. Machine learning based analytics of micro-MRI trabecular bone microarchitecture and texture in type 1 Gaucher disease.
Sharma GB; Robertson DD; Laney DA; Gambello MJ; Terk M
J Biomech; 2016 Jun; 49(9):1961-1968. PubMed ID: 27109052
[TBL] [Abstract][Full Text] [Related]
19. Standardization of MRI and Scintigraphic Scores for Assessing the Severity of Bone Marrow Involvement in Adult Patients With Type 1 Gaucher Disease.
Mariani G; Perri M; Minichilli F; Ortori S; Linari S; Giona F; Di Rocco M; Cappellini MD; Guidoccio F; Erba PA
AJR Am J Roentgenol; 2016 Jun; 206(6):1245-52. PubMed ID: 27057587
[TBL] [Abstract][Full Text] [Related]
20. Spontaneous regression of disease manifestations can occur in type 1 Gaucher disease; results of a retrospective cohort study.
Boomsma JM; van Dussen L; Wiersma MG; Groener JE; Aerts JM; Maas M; Hollak CE
Blood Cells Mol Dis; 2010 Mar; 44(3):181-7. PubMed ID: 20074983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
